Ocrevus 300 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DR26F52RG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,638
Award facts
- Contract value 100% obligated
- $25,637.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $25,637.70 delivery order to Amerisourcebergen Drug Corp on July 13, 2026, for Ocrevus 300 mg/10 ml vial pharmaceutical supply, with an ultimate completion date of August 3, 2026.
Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a pharmaceutical distributor supplying medications and medical devices to federal healthcare systems and the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26F52RG?
SPE2DR26F52RG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 13, 2026.
How much is contract SPE2DR26F52RG worth?
The government has obligated $25,638 on SPE2DR26F52RG.
Is contract SPE2DR26F52RG an order under another contract?
Yes. SPE2DR26F52RG is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F52RG competed?
The extent of competition for SPE2DR26F52RG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award